BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7540556)

  • 1. Evidence for a lymphotropic nature of circulating plasmacytoid monocytes: findings from a case of CD56+ chronic myelomonocytic leukemia.
    Horny HP; Kaiserling E; Handgretinger R; Ruck P; Frank D; Weber R; Jaschonek KG; Waller HD
    Eur J Haematol; 1995 Apr; 54(4):209-16. PubMed ID: 7540556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated lymph node infiltrates of plasmacytoid monocytes (so-called plasmacytoid T-cells). Evidence for two distinct histological and immunophenotypical patterns.
    Facchetti F; De Wolf-Peeters C; Kennes C; Rossi G; De Vos R; van den Oord JJ; Desmet VJ
    Am J Surg Pathol; 1990 Feb; 14(2):101-12. PubMed ID: 2301697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization.
    Harris NL; Demirjian Z
    Am J Surg Pathol; 1991 Jan; 15(1):87-95. PubMed ID: 1845925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells.
    Kojima H; Bai A; Mukai HY; Hori M; Komeno T; Hasegawa Y; Ninomiya H; Mori N; Nagasawa T
    Leuk Lymphoma; 2000 May; 37(5-6):617-21. PubMed ID: 11042523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD56+CD68+hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3.
    Ko YH; Kim SH; Park K; Ree HJ
    J Korean Med Sci; 2002 Dec; 17(6):833-9. PubMed ID: 12483012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
    Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytoid dendritic cell leukemia in children.
    Hama A; Kudo K; Itzel BV; Muramatsu H; Nishio N; Yoshida N; Takahashi Y; Yagasaki H; Ito M; Kojima S
    J Pediatr Hematol Oncol; 2009 May; 31(5):339-43. PubMed ID: 19415013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid monocyte proliferation associated with myeloproliferative disorders.
    Baddoura FK; Hanson C; Chan WC
    Cancer; 1992 Mar; 69(6):1457-67. PubMed ID: 1540883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous occurrence of myelomonocytic leukemia and multiple myeloma: involvement of common leukemic progenitors and their developmental abnormality of "lineage infidelity".
    Akashi K; Harada M; Shibuya T; Fukagawa K; Kimura N; Sagawa K; Yoshikai Y; Teshima T; Kikuchi M; Niho Y
    J Cell Physiol; 1991 Sep; 148(3):446-56. PubMed ID: 1655817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders.
    Vermi W; Facchetti F; Rosati S; Vergoni F; Rossi E; Festa S; Remotti D; Grigolato P; Massarelli G; Frizzera G
    Am J Surg Pathol; 2004 May; 28(5):585-95. PubMed ID: 15105645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid T-cell lymphoma associated with chronic myeloproliferative disorder.
    Prasthofer EF; Prchal JT; Grizzle WE; Grossi CE
    Am J Surg Pathol; 1985 May; 9(5):380-7. PubMed ID: 3879106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
    Jensen GS; Mant MJ; Pilarski LM
    Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.
    Reuss-Borst MA; Steinke B; Waller HD; Bühring HJ; Müller CA
    Ann Hematol; 1992 Feb; 64(2):78-82. PubMed ID: 1372833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A 45-year-old man with peripheral monocytosis and right hemiparesis].
    Takubo H; Hattori N; Irie S; Mizutani Y; Mori H; Suda K; Kondo T; Oshimi K; Mizuno Y
    No To Shinkei; 1998 May; 50(5):481-9. PubMed ID: 9621375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.
    Garnache-Ottou F; Chaperot L; Biichle S; Ferrand C; Remy-Martin JP; Deconinck E; de Tailly PD; Bulabois B; Poulet J; Kuhlein E; Jacob MC; Salaun V; Arock M; Drenou B; Schillinger F; Seilles E; Tiberghien P; Bensa JC; Plumas J; Saas P
    Blood; 2005 Feb; 105(3):1256-64. PubMed ID: 15388576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloblastoma formation in acute myeloid leukemia.
    Iizuka Y; Aiso M; Oshimi K; Kanemaru M; Kawamura M; Takeuchi J; Horikoshi A; Ohshima T; Mizoguchi H; Horie T
    Leuk Res; 1992; 16(6-7):665-71. PubMed ID: 1378918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.